The U.S. Food and Drug Administration (FDA) and McNeil Consumer Health care (a division of Johnson & Johnson) have issued a nationwide recall of certain children's Tylenol products. The voluntary drug recall was issued after the company discovered a possible bacterial contamination of their popular infant and children’s pain and fever medicines.

The Tylenol maker discovered one of the inactive ingredients, of the children’s over-the-counter preparation, did not meet testing requirements for the bacteria, B. Cepacia (Burkholderia cepacia). Leaders with Johnson & Johnson, a worldwide manufacturer based in New Brunswick, New Jersey, assert the Tylenol recall affects only the United States market and certain Tylenol products manufactured between April and June of 2008. No adverse events from the recalled drug have been reported.